跳至主要内容
临床试验/JPRN-C000000442
JPRN-C000000442未知4 期

Effects of 5 ARBs on blood pressure, glucose and lipid metabolism, renal and heart function, and inflammation markers (Earnest) - Earnest

Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Department of Endocrinology and Metabolism0 个研究点目标入组 300 人开始时间: 2006年7月5日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients already receiving ARBs Pregnant women, or women suspected of being pregnant Hyperkalemia Bilateral renal artery stenosis Patients with history of hypersensitivity to the administered ARB Patients with severe liver disorder (losartan) Patients with severe defect in biliary drainage from liver or severe hepatic disorder (telmisartan)

研究者

发起方
Yokohama City University Graduate School of Medicine Department of Medical Science and Cardiorenal Medicine Department of Endocrinology and Metabolism

相似试验